Africa lags behind in knowledge conversion in biomedicine
African governments allocate little to no investments on exploration of knowledge that would lead to discovery of bio-medical facts, theories and propositions. Furthermore, African governments invest very little on research that would lead to verification of facts, theories and propositions. Most investments in bio-medical research in Africa are from foreign sources such as development agencies of Western nations and Japan. The tragedy is that Western nations and Japan invest in discovery and verification of knowledge for the benefit of the citizens of their respective countries. They do not invest in discovery and verification for the benefit of the citizens of African countries. Instead, they use the citizens of Africa to exploit local resources to discover and verify matters of interest to them. Presence of the foreign research enterprise in Africa is an illusion to Africa’s possibility for discovery and verification. To overcome this problem, African countries must allocate a substantial percentage of its gross domestic product (GDP) to discovery and verification of knowledge in biomedicine.
Much worse, the African governments invest absolutely nothing to publication and translation. The absence of will to publish and translate medical knowledge leaves practitioners in the field without resources to use to promote health, prevent or treat diseases. Because of this problem many medical problems incident in Africa are poorly understood. The infrastructure for delivery of care is decrepit. The quality of care is extremely poor. Care is expensive. Medical equipment are lacking and where present are poorly maintained. Good medicines are expensive and out of reach by majority of Africans.